| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_73aec6ea0f83ed93e7f17fd860893c61 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57423
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6851 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6851
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 |
| filingDate |
2021-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_689e351066ccc8c06bb35ee6d1969c5c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2cedc7b7bd7fe24192dae66259a60fa1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ced4394b0eb2495e9da3d01cf5bbc418 |
| publicationDate |
2022-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-114196756-A |
| titleOfInvention |
Lung squamous carcinoma adjuvant immunotherapy target gene LINC00890 detection kit and application |
| abstract |
The invention belongs to the technical field of biology, and relates to a lung squamous carcinoma adjuvant immunotherapy target gene LINC00890 detection kit and application thereof. The research of the invention proves that the LINC00890 expression in the squamous cell lung carcinoma is obviously reduced. The LINC00890 expression level is positively correlated with immune microenvironment indexes of StromalScore, ImmuneScore and ESTIMMATEScore, is positively correlated with infiltration of various immune cells and is positively correlated with the expression of immune checkpoint genes, so that the LINC00890 can be used as a new target for lung squamous carcinoma immunotherapy. |
| priorityDate |
2021-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |